Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Board Changes

30 Mar 2020 07:01

RNS Number : 9565H
Kier Group PLC
30 March 2020
 

Kier Group plc

Board Changes

Kier Group plc (the "Company" or the "Group") announces the appointments of Mr. Clive Watson and Dame Heather Rabbatts to its board of directors (the "Board") with immediate effect.

Clive Watson is currently a non-executive director of Breedon Group plc and discoverIE Group plc, where he is the Chair of the Audit and Risk Committee, having previously been a non-executive director of Spirax-Sarco Engineering plc, where he was the Senior Independent Director and the Chair of the Audit Committee. During his executive career, Clive was the Group Finance Director at Spectris plc from 2006-2019, having previously held a number of senior finance positions at Borealis, Thorn Lighting Group and The Black & Decker Corporation.

Clive will be the Chair of the Risk Management and Audit Committee and a member of the Nomination Committee, the Remuneration Committee and the Safety, Health and Environment Committee.

Justin Atkinson will stand down from the role of acting Chair of the Risk Management and Audit Committee with immediate effect and continue in the role of Senior Independent Director.

Heather Rabbatts has held a number of executive and non-executive positions in the local government, entertainment and sport sectors, in particular. Heather is currently the Chair of Soho Theatre Company and her recent non-executive directorships include Crossrail, the Football Association, where she was a member of the Remuneration Committee, and Grosvenor Britain & Ireland, where she was the Chair of the Audit Committee.

Heather will be the Chair of the Remuneration Committee and a member of the Nomination Committee, the Risk Management and Audit Committee and the Safety, Health and Environment Committee.

Constance Baroudel, the current Chair of the Remuneration Committee, will stand down from the Board with immediate effect.

Matthew Lester, Chairman, said: "We are delighted that Clive and Heather will be joining the Board. Both have a depth of experience which will be invaluable as the Board continues to oversee the delivery of the Group's strategic objectives. I look forward to working with Clive and Heather.

I would like to thank Constance for her contribution over almost four years on the Board. I would also like to thank Justin for undertaking the role of Chair of the Risk Management and Audit Committee on an interim basis.

As the Chair of the Remuneration Committee, Heather will be engaging with shareholders with respect to the Company's revised remuneration policy, which will assist her to understand the reasons for the significant vote against the Directors' Remuneration Report at the 2019 AGM and to consider any actions which may need to be taken as a result."

In relation to the appointment of Clive Watson, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

In relation to the appointment of Heather Rabbatts, no information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Further information

Please contact:

 

Kier Press Office 

+44 (0)1767 355 096

Richard Mountain/Nick Hasell - FTI Consulting 

+44 (0)20 3727 1340

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMZGZFRLKGGZM
Date   Source Headline
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20253:13 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 202511:06 amRNSHolding(s) in Company
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSNotice of Results and Presentations
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20254:51 pmRNSHolding(s) in Company
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202512:28 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20254:48 pmRNSHolding(s) in Company
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20252:01 pmRNSHolding(s) in Company
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 202512:17 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 202510:35 amRNSHolding(s) in Company
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 202512:38 pmRNSHolding(s) in Company
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20253:56 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 202511:15 amRNSHolding(s) in Company
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20254:42 pmRNSHolding(s) in Company
7th Aug 20251:46 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 202511:33 amRNSHolding(s) in Company
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:02 amRNSHolding(s) in Company
1st Aug 202510:59 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 202512:38 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20254:34 pmRNSHolding(s) in Company
29th Jul 20252:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.